- Home
- NBY vs SNEX Comparison
NBY vs SNEX Comparison
Compare NBY & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- SNEX
- Stock Information
- Founded
- NBY 2000
- SNEX 1924
- Country
- NBY United States
- SNEX United States
- Employees
- NBY N/A
- SNEX N/A
- Industry
- NBY
- SNEX Investment Bankers/Brokers/Service
- Sector
- NBY
- SNEX Finance
- Exchange
- NBY Nasdaq
- SNEX Nasdaq
- Market Cap
- NBY 3.5M
- SNEX N/A
- IPO Year
- NBY 2007
- SNEX 1994
- Fundamental
- Price
- NBY $0.71
- SNEX $83.34
- Analyst Decision
- NBY
- SNEX
- Analyst Count
- NBY 0
- SNEX 0
- Target Price
- NBY N/A
- SNEX N/A
- AVG Volume (30 Days)
- NBY 7.7M
- SNEX 101.7K
- Earning Date
- NBY 11-07-2024
- SNEX 11-13-2024
- Dividend Yield
- NBY N/A
- SNEX N/A
- EPS Growth
- NBY N/A
- SNEX N/A
- EPS
- NBY N/A
- SNEX 7.22
- Revenue
- NBY $13,884,000.00
- SNEX $84,272,200,000.00
- Revenue This Year
- NBY N/A
- SNEX N/A
- Revenue Next Year
- NBY $26.04
- SNEX $1.01
- P/E Ratio
- NBY N/A
- SNEX $11.50
- Revenue Growth
- NBY 4.06
- SNEX 40.64
- 52 Week Low
- NBY $0.36
- SNEX $57.46
- 52 Week High
- NBY $15.40
- SNEX $84.92
- Technical
- Relative Strength Index (RSI)
- NBY 55.65
- SNEX 59.27
- Support Level
- NBY $0.64
- SNEX $79.82
- Resistance Level
- NBY $0.71
- SNEX $84.92
- Average True Range (ATR)
- NBY 0.08
- SNEX 1.78
- MACD
- NBY 0.02
- SNEX -0.04
- Stochastic Oscillator
- NBY 43.40
- SNEX 69.02
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.